[(2R,3S)-2,3,7-trimethyl-6-octenoyl]-(4'R)-benzyl-2'-oxazolidinone

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: [(2R,3S)-2,3,7-trimethyl-6-octenoyl]-(4'R)-benzyl-2'-oxazolidinone
• 英文别名: 3(2(R),3(S),7-trimethyl-6-octenoyl)-4(R)-phenylmethyl-2-oxazolidinone；(4R)-4-benzyl-3-[(2R,3S)-2,3,7-trimethyloct-6-enoyl]-1,3-oxazolidin-2-one
• 化学式: C₂₁H₂₉NO₃
• 分子量: 343.466
• InChiKey: BVDCVSUIYLGYMF-YQVWRLOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.5
• 重原子数：
  25
• 可旋转键数：
  7
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.52
• 拓扑面积：
  46.6
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  [(2R,3S)-2,3,7-trimethyl-6-octenoyl]-(4'R)-benzyl-2'-oxazolidinone 在 sodium tetrahydroborate 作用下， 以 四氢呋喃 、 水 为溶剂， 反应 36.0h， 以87%的产率得到(2R,3S)-2,3,7-trimethyl-6-octen-1-ol
  参考文献：
  名称：

  Concise Formation of Spirocyclic Compounds for Marine Phycotoxins

  摘要：

  The stereoselective construction of azaspiro[5.6]dodecenone skeletons by the chiral BOX/copper-mediated Diels-Alder reaction is described. The cycloaddition reaction of alpha-methylene caprolactams and functionalized dienes allows the concise formation of spirocyclic structures of marine phycotoxins, such as pinnatoxin and spirolide.

  DOI：

  10.3987/com-16-s(s)34
• 作为产物：
  描述：

  (S)-(-)-香茅酸 、 (R)-4-苄基-2-噁唑烷酮 在 sodium hexamethyldisilazane 、 三甲基乙酰氯 、 三乙胺 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 9.8h， 生成 [(2R,3S)-2,3,7-trimethyl-6-octenoyl]-(4'R)-benzyl-2'-oxazolidinone
  参考文献：
  名称：

  Concise Formation of Spirocyclic Compounds for Marine Phycotoxins

  摘要：

  The stereoselective construction of azaspiro[5.6]dodecenone skeletons by the chiral BOX/copper-mediated Diels-Alder reaction is described. The cycloaddition reaction of alpha-methylene caprolactams and functionalized dienes allows the concise formation of spirocyclic structures of marine phycotoxins, such as pinnatoxin and spirolide.

  DOI：

  10.3987/com-16-s(s)34

文献信息

• Cyclic amidine analogs as inhibitors of nitric oxide synthase
  申请人：Merck & Co., Inc.

  公开号：US05629322A1

  公开（公告）日：1997-05-13

  Disclosed herein are compounds of Formula I ##STR1## and pharmaceutically acceptable salts thereof which have been found useful in the treatment of nitric oxide synthase mediated diseases and disorders, including neurodegenerative disorders, disorders of gastrointestinal motility and inflammation. These disease and disorders include hypotension, septic shock, toxic shock syndrom, hemodialysis, IL-2 therapy such as in cancer patients, cachexia, immunosuppression such as in transplant therapy, autoimmune and/or inflammatory indications including sunburn or psoriasis and respiratory conditions such as bronchitis, asthma, and acure respiratory distress (ARDS), myocarditis, heart failure, atherosclerosis, arthritis, rheumatoid arthritis, chronic or inflammatory bowel disease, ulcerative colitis, Crohn's disease, systemic lupus erythematosis (SLE), ocular conditions such as ocular hypertension and uveitis, type 1 diabetes, insulin-dependent diabetes mellitus and cystic fibrosis. Compounds of Formula I are also usful in the treatment of hypoxia, hyperbaric oxygen convulsions and toxicity, dementia, Sydenham's chorea, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, mulitple sclerosis, Korsakoff's disease, imbecility related to cerebral vessel disorder, ischemic brain edema, sleeping disorders, schizophrenia, depression, PMS, anxiety, drug addiction, pain, migraine, immune complex disease, as immunosupressive agents and for preventing or reversing tolerance to opiates and diazepines.

  本文公开了I式化合物##STR1##及其药学上可接受的盐，发现其在治疗一氧化氮合酶介导的疾病和疾病方面有用，包括神经退行性疾病，胃肠动力障碍和炎症。这些疾病和疾病包括低血压，败血症休克，毒性休克综合征，血液透析，癌症患者的IL-2治疗，消瘦，移植治疗中的免疫抑制，自身免疫和/或炎症指示包括晒伤或银屑病以及呼吸系统疾病，如支气管炎，哮喘和急性呼吸窘迫综合征（ARDS），心肌炎，心力衰竭，动脉硬化，关节炎，类风湿性关节炎，慢性或炎症性肠病，溃疡性结肠炎，克隆病，系统性红斑狼疮（SLE），眼部疾病，如眼压和葡萄膜炎，1型糖尿病，胰岛素依赖性糖尿病和囊性纤维化。I式化合物也适用于治疗低氧，高压氧惊厥和毒性，痴呆，希登汉姆舞蹈病，帕金森病，亨廷顿病，肌萎缩性侧索硬化，多发性硬化，科萨科夫氏综合征，与脑血管疾病相关的低能力，缺血性脑水肿，睡眠障碍，精神分裂症，抑郁症，PMS，焦虑症，药物成瘾，疼痛，偏头痛，免疫复合物疾病，作为免疫抑制剂，并用于预防或逆转对鸦片类和苯二氮平的耐受性。
• EP0789571A4
  申请人：——

  公开号：EP0789571A4

  公开（公告）日：1999-04-14
• CYCLIC AMIDINE ANALOGS AS INHIBITORS OF NITRIC OXIDE SYNTHASE
  申请人：MERCK & CO., INC.

  公开号：EP0789571A1

  公开（公告）日：1997-08-20
• US5629322A
  申请人：——

  公开号：US5629322A

  公开（公告）日：1997-05-13
• [EN] CYCLIC AMIDINE ANALOGS AS INHIBITORS OF NITRIC OXIDE SYNTHASE<br/>[FR] ANALOGUES D'AMIDINES CYCLIQUES UTILISES COMME INHIBITEURS DE LA MONOXYDE D'AZOTE SYNTHETASE
  申请人：MERCK & CO., INC.

  公开号：WO1996014844A1

  公开（公告）日：1996-05-23

  (EN) Disclosed herein are the heterocyclic compounds and pharmaceutically acceptable salts thereof which have been found to be useful in the treatment of nitric oxide synthase mediated diseases and disorders.(FR) L'invention concerne des composés hétérocycliques et des sels pharmaceutiquement acceptables de ceux-ci qui se sont montrés utilesdans le traitement des maladies et des troubles liés à la monoxyde d'azote synthétase.